Library

1T-LSD

1T-LSD, also known as 1-(thiophene-2-carbonyl)-LSD or as SYN-L-021, is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. It was first identified in Japan in 2023 on blotter paper misrepresented as containing 1D-LSD, but which on analysis was determined to contain 1T-LSD instead. It was also detected in Germany around the same time.

Also known as: 1-Thiophenoyl-LSD

Classification

  • Chemical: Lysergamide
  • Psychoactive: Psychedelic

Effects

  • Dilated Pupils
  • Stimulation
  • Nausea
  • Pupil Dilation
  • Spontaneous Tactile Sensations
  • Introspection
  • Euphoria
  • Time Distortion
  • Analysis Enhancement
  • Memory Suppression
  • Conceptual Thinking
  • Visual Distortion
  • Color Enhancement
  • Drifting
  • Tracers
  • Pattern Recognition Enhancement

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

1T-LSD - Treoir substaint DrugsPRO

1T-LSD: 1T-LSD, also known as 1-(thiophene-2-carbonyl)-LSD or as SYN-L-021, is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. It was first identified in Japan in 2023 on blotter paper misrepresented as containing 1D-LSD, but which on analysis was

Related pages